Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

Cancer Research
Barbara ValzasinaMario P Colombo

Abstract

The CD25- and CD25+ CD4 T-lymphocyte compartments are tightly regulated. We show here that tumors break such balance, increasing the number of CD4+CD25+ T cells in draining lymph node and spleen but not contralateral node of tumor-bearing mice. Tumor injection in thymectomized and CD25-depleted mice shows that CD4+CD25+ T-cell expansion occurs even in the absence of the thymus and independently from proliferation of preexisting CD25+ T cells. These newly generated cells are bona fide regulatory T cells (T reg) in terms of Foxp3 expression and suppression of CD3-stimulated or allogeneic effector cell proliferation. Transfer of congenic Thy1.1 CD4+CD25- T cells, from mice treated or not with vinblastine, into tumor-bearing or tumor-free mice and analysis of recovered donor lymphocytes indicate that conversion is the main mechanism for acquiring the expression of CD25 and Foxp3 through a process that does not require proliferation. Although conversion of CD4+CD25- T cells for generation of T regs has been described as a natural process that maintains peripheral T-reg population, this process is used by the tumor for immune escape. The prompt recovery of T regs from monoclonal antibody-mediated CD25 depletion in tumor-bearing mice ...Continue Reading

References

Apr 29, 1998·Nature·M Baggiolini
May 23, 1998·Annual Review of Immunology·J J Letterio, A B Roberts
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·F Lepault, M C Gagnerault
Jan 10, 2001·International Journal of Cancer. Journal International Du Cancer·J A McEarchernE T Akporiaye
Feb 13, 2001·Journal of Cellular Physiology·B Pasche
Jun 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K M Thorstenson, A Khoruts
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Veronika SzanyaC Garrison Fathman
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Udaya K LiyanageDavid C Linehan
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Afonso R M AlmeidaAntónio A Freitas
Oct 31, 2002·Immunology and Cell Biology·Karen L LauriePaul A Gleeson
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Jan 31, 2003·European Journal of Immunology·Denise GolgherAwen Gallimore
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Massimo C FantiniMarkus F Neurath
Jul 2, 2004·Nature Reviews. Cancer·Fran Balkwill
Sep 24, 2004·The Journal of Experimental Medicine·Mary Jo TurkAlan N Houghton
Dec 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria A Curotto de LafailleJuan J Lafaille
Dec 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simon J PrasadFranca Ronchese
Jan 5, 2005·The Journal of Experimental Medicine·Shuang LiangMichele M Kosiewicz
Feb 1, 2005·Journal of Translational Medicine·Ji-Yan LiuYi-Xin Zeng
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Santiago ZelenayJocelyne Demengeot
Sep 28, 2005·The Journal of Experimental Medicine·François GhiringhelliLaurence Zitvogel
Oct 26, 2005·Nature Immunology·Karsten KretschmerHarald von Boehmer
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alberto ComesSilvano Ferrini

❮ Previous
Next ❯

Citations

May 10, 2007·Cancer Immunology, Immunotherapy : CII·Richard W GriffithsRobert E Hawkins
Apr 21, 2007·Cancer Immunology, Immunotherapy : CII·Emma di CarloSilvano Ferrini
Nov 15, 2008·Cancer Immunology, Immunotherapy : CII·Christine GalustianAngus G Dalgleish
Apr 27, 2011·Cancer Immunology, Immunotherapy : CII·Masato KatoKingo Chida
Apr 2, 2008·Current Oncology Reports·Marc Beyer, Joachim L Schultze
Oct 30, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·C TanchotE Tartour
May 7, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zuqiang LiuZhaoyang You
Oct 25, 2007·Nature Reviews. Cancer·Mario P Colombo, Silvia Piconese
Jul 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Li WangRandolph J Noelle
Mar 26, 2008·The Journal of Experimental Medicine·Silvia PiconeseMario P Colombo
May 6, 2009·The Journal of Experimental Medicine·Daniel Hirschhorn-CymermanAlan N Houghton
Sep 12, 2012·The Journal of Experimental Medicine·Jonathan M WeissJuan J Lafaille
Sep 13, 2011·Neuro-oncology·Derek A WainwrightMaciej S Lesniak
Nov 24, 2011·Clinical & Developmental Immunology·Nona JanikashviliNicolas Larmonier
Mar 9, 2012·Clinical & Developmental Immunology·Zhi-Chun Ding, Gang Zhou
Nov 26, 2010·Cancer Research·Natalia Martin-OrozcoLaszlo Radvanyi
May 3, 2012·Cancer Research·Andrea FacciabeneGeorge Coukos
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karsten A PilonesSandra Demaria
Jun 17, 2008·American Journal of Respiratory and Critical Care Medicine·Pradeep R RaiNorbert F Voelkel
May 4, 2007·The Journal of Clinical Investigation·David H Munn, Andrew L Mellor
Nov 21, 2007·Blood·Young-June KimHal E Broxmeyer
Mar 13, 2012·World Journal of Gastroenterology : WJG·Dong HuaXue-Guang Zhang
Aug 13, 2010·Clinical Medicine Insights. Oncology·Joseph F Murphy
Jul 20, 2010·Immunotherapy·Takayuki YoshimotoJunichiro Mizuguchi
Jan 10, 2012·Annual Review of Immunology·Angelina M Bilate, Juan J Lafaille
Jul 10, 2014·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Eleonora ReginatoPeter Wolf
Dec 17, 2014·Journal of the National Cancer Institute·Dhafer MrizakNadira Delhem
Nov 2, 2014·Cancer Metastasis Reviews·Elizabeth C HalvorsenKevin L Bennewith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.